Closing the portal to SARS-CoV-2 cellular entry: May open newer avenues.

Sharma, Ridhima; Magoon, Rohan; Kaushal, Brajesh

Closing the portal to SARS-CoV-2 cellular entry: May open newer avenues.

Sharma, Ridhima; Magoon, Rohan; Kaushal, Brajesh.

Sharma R; Department of Paediatric Anaesthesia, Superspeciality Paediatric Hospital & Postgraduate Teaching Institute, Noida 201301, India.
Magoon R; Department of Cardiac Anaesthesia, Atal Bihari Vajpayee Institute of Medical Sciences (ABVIMS) and Dr. Ram Manohar Lohia Hospital, Baba Kharak Singh Marg, New Delhi 110001, India.
Kaushal B; Department of Anaesthesia, Gandhi Medical College and Hamidia Hospital, Bhopal 462001, Madhya Pradesh, India. Electronic address: brajeshkaushal3@gmail.com.

Med Hypotheses ; 146: 110464, 2021 01.

Article in English | MEDLINE | ID: covidwho-988861

Subject(s)

COVID-19; Thrombosis; Humans; Peptidyl-Dipeptidase A; SARS-CoV-2; Virus Internalization

Keywords

COVID-19; Camostat mesylate; Cellular entry; Nafamostat mesylate; SARS-CoV-2 pneumonia; Thrombosis; Transmembrane protease serine 2 (TMPRSS2)

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Thrombosis / COVID-19 Limits: Humans Language: English Journal: Med Hypotheses Year: 2021 Document Type: Article Affiliation country: J.mehy.2020.110464

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google